作者：
Paul J,Bröckelmann [1]
;
Ina,Bühnen [1]
;
Julia,Meissner [2]
;
Karolin,Trautmann-Grill [3]
;
Peter,Herhaus [4]
;
Teresa V,Halbsguth [5]
;
Valdete,Schaub [6]
;
Andrea,Kerkhoff [7]
;
Stephan,Mathas [8]
;
Matthias,Bormann [9]
;
Andreas,Dickhut [10]
;
Helen,Kaul [1]
;
Michael,Fuchs [1]
;
Carsten,Kobe [11]
;
Christian,Baues [12]
;
Peter,Borchmann [1]
;
Andreas,Engert [1]
;
Bastian,von Tresckow [1]
作者单位：
University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), Cologne, Germany.
[1]
Medicine V, University of Heidelberg, Heidelberg, Germany.
[2]
University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[3]
Technical University Munich, School of Medicine, Klinikum rechts der Isar, Clinic and Policlinic for Internal Medicine III, Munich, Germany.
[4]
Division of Hematology/Oncology, Department of Medicine II, Goethe University Hospital Frankfurt, Frankfurt, Germany.
[5]
University Hospital Tübingen, Tübingen, Germany.
[6]
Medizinische Klinik A, University Hospital Muenster, Muenster, Germany.
[7]
Division of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
[8]
Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany.
[9]
Tumorklinik, Klinikum Fulda, Fulda, Germany.
[10]
Department of Nuclear Medicine and GHSG, University Hospital of Cologne, Cologne, Germany.
[11]
Department of Radiation Oncology and GHSG, University Hospital of Cologne, Cologne, Germany.
[12]
Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
[13]
DOI
10.1200/JCO.22.02355
PMID
36508302
发布时间
2023-04-03
换一批
换一批
